Member Info for Laura2022

Tony

No problem

Ive been loading GENI TRT and as of today NANO

Yes

See the original RNS

Almost all gone to holders and BOD

Going well

Tony

The date of yesterday is because thats when they were OFFICIALLY issued

They bought in placing

Tony

Yes

Both added in placing

Octopus also

3rd TR1

Octopus

First equity new holder

Maven added 20mln shares

Very sticky as I said 2 weeks ago

Hardly any will have gone to non - TR1

Nice TR1

I filtered their latest new ID

Will soon be NT to buy and once GENI moves it will be fast omho

Oversold and got to be worth a flutter at 5.8pp??

They have 2-3 years of cash at current cash burn rates. Bradley Wayne Caldwell, used to litigate against Samsung and LG (Shoei customer) have extensive knowledge of Nanoco's IP and have advised a counterclaim against Shoei. Shoei was not expecting this, they just wanted clarity on its IP and that it was not infringing on Nanaoco. I suspect a large cash return from Shoei, back to back with the sale of Nanoco to them

The FTSE 100 opened at a record high, above 10,500, as financials were lifted by Schroders’ £10bn takeover deal. Given the fear-driven sell-off in this space this week, it seems an opportune moment to stress the benefits of scale for fund managers at a time of immense disruption from AI.

 

Schroders shares leapt 30 per cent to the offer price of 590p, 

Think SPI will be next

Nice buying eg

£160.68k

Thanks for that IANO very interesting

That's 7 new contraxts in just 2 months

And a second asia client ( Astellas being a long term one)

Another peer hasn't for example won a contract for over 5mths

This new project is with a South Korean clinical stage biopharmaceutical company focused on the development of next-generation antibody drug conjugate (ADC) and Immuno-oncology therapeutic for the treatment of cancer. Under the terms of the contract, Physiomics will use PK/PD modelling and simulation techniques to support dosing decisions for one of the client's clinical stage assets. The project, valued at up to £66,600, will commence immediately with completion anticipated within the next two months.

Largest buy for many months

Banbury

There's some lovely low cost housing which has absolutely nothing to do or gain for RRR if that helps

:)

It's the 1.25mln trade buy thats not showing

Lse been a but tardy recently in publishing trades currently

So this week a 1.5mln and a 1.25mln buy

Even in August it was unsustainable

Net debt increased in period due to usual seasonal cash flow profile; balance sheet derisking continues

− Net debt increased in H1 2025 as expected, reflecting typical seasonal net working capital patterns, capital expenditure phasing and FX translation; non-recurring cash outflows reduced significantly as expected

− Covenant net debt: EBITDA ratio of 4.8x as at end June; £430m+ in committed liquidity prior to £129m repayment of the remaining 2025 bonds in early July; covenants relaxed until end of 2026

 

The level of debt here last 3yrs is staggering